Studies have shown that active fund managers routinely underperform the S&P500 index*​

Carlsmed, Inc. (NASDAQ: CARL)

CARL Stock Predictions and Ratings

WSX Rating:
BUY
WSX Forecast (1yr):
34.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-6.90%

CARL Stock Analysis

CARL PE Ratio:

CARL PEG Ratio: Not Available

CARL Forward EPS Growth (12 month): 0.00%

CARL PS Ratio: 4.9

CARL PSG Ratio: 0.1

CARL Forward Revenue Growth (12 month): 40.20%

CARL Articles

No data was found